Why the U.S. Is Underestimating Covid Reinfection
Hundreds of Americans suspect they contracted covid early in the pandemic and recovered, only to get infected again months later. But because the U.S. does so little genetic sequencing of covid samples, we don’t know much about reinfection rates.
Por qué Estados Unidos subestima las reinfecciones por covid
Aunque se definen como “raras”, habría muchas reinfecciones por covid. El problema es que Estados Unidos no tiene la capacidad para hacer el análisis genético necesario para detectarlas.
Patients Fend for Themselves to Access Highly Touted Covid Antibody Treatments
Months after President Donald Trump credited monoclonal antibody therapy for his quick recovery from covid-19, only a trickle of the product has found its way into regular people. While hundreds of thousands of vials sit unused, sick patients who might benefit from early treatment have been left on their own to vie for access.
Is Your Covid Vaccine Venue Prepared to Handle Rare, Life-Threatening Reactions?
More than two dozen people who have received the new covid vaccines in U.S. hospitals and health centers suffered anaphylaxis, a potentially fatal allergic reaction. While such severe reactions are rare, experts warn that the drugstores and drive-thru clinics considered integral to the vaccine rollout must be prepared.
At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine
Months before federal officials authorized experimental vaccines to ward off the coronavirus in humans, scientists tried a veterinary vaccine in endangered ferrets. Drugmakers are researching similar efforts for other animals proving vulnerable to the virus, such as farmed minks, in part to guard against virus mutations that could pose new risks to people.
Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots
Even as the federal Food and Drug Administration engaged in intense deliberations ahead of Friday’s authorization of the nation’s first COVID vaccine, and days before the initial doses were to be released, hospitals have been grappling with how to distribute the first scarce shots. Their plans vary broadly.
Desafío en hospitales: a qué trabajadores de salud vacunar primero contra COVID
Se aconseja a los hospitales que cubran a los miembros de su fuerza laboral con mayor riesgo, pero deben decidir exactamente quiénes serán mientras no haya dosis suficientes.
Demand for COVID Vaccines Expected to Get Heated — And Fast
With two vaccines against coronavirus disease poised for release within weeks, experts say they expect attitudes to shift dramatically from hesitancy to “Beanie Baby”-level urgency.
New Legal Push Aims to Speed Magic Mushrooms to Dying Patients
A proposal in Washington state would use right-to-try laws to allow terminally ill patients access to psilocybin — the famed magic mushrooms of America’s psychedelic ’60s — to ease depression and anxiety.
Time to Discuss Potentially Unpleasant Side Effects of COVID Shots? Scientists Say Yes.
From the likelihood of achy, flu-like side effects to the need for two doses, weeks apart, consumers need to know now what to expect when vaccines to prevent COVID-19 roll out.